Invasive Escherichia coli vaccines expressing Brucella melitensis outer membrane proteins 31 or 16 or periplasmic protein BP26 confer protection in mice challenged with B. melitensis

Vaccine

Volumn 30, Issue 27, 2012, Pages 4017-4022

  Gupta, V K ^a   Radhakrishnan, G ^b   Harms, J ^b   Splitter, G ^b  

^a CENTRAL INSTITUTE FOR RESEARCH ON GOATS   (India)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Brucella melitensis; Brucella Omps31; Invasive e. coli vaccine; Mice; Omps16; Periplasmic protein BP26

Indexed keywords

CYTOKINE; ESCHERICHIA COLI VACCINE; INVASIN; OUTER MEMBRANE PROTEIN; OUTER MEMBRANE PROTEIN 16; OUTER MEMBRANE PROTEIN 31; PERIPLASMIC PROTEIN; PERIPLASMIC PROTEIN BP26; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GENE; BRUCELLOSIS; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXICITY; ESCHERICHIA COLI; HUMORAL IMMUNITY; INV BACTERIAL GENE; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; SPLEEN CELL; WESTERN BLOTTING;

ANIMALS; BACTERIAL LOAD; BACTERIAL OUTER MEMBRANE PROTEINS; BRUCELLA MELITENSIS; BRUCELLA VACCINE; BRUCELLOSIS; CYTOKINES; DISEASE MODELS, ANIMAL; DRUG CARRIERS; ESCHERICHIA COLI; FEMALE; GENETIC VECTORS; LEUKOCYTES, MONONUCLEAR; LISTERIA MONOCYTOGENES; MICE; MICE, INBRED BALB C; PERIPLASMIC PROTEINS; SPLEEN; YERSINIA PSEUDOTUBERCULOSIS;

EID: 84861480849     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.04.036     Document Type: Article

References (46)

1. Maudlin I., Weber S. The control of neglected zoonotic diseases: a route to poverty alleviation 2006, WHO, Geneva.
2. Alton G.G., Elberg S.S., Crouch D. Rev. 1 Brucella melitensis vaccine. The stability of the degree of attenuation. Journal of Comparative Pathology 1967, 77:293-300.
3. Zhan Y., Cheers C. Control of IL-12 and IFN-gamma production in response to live or dead bacteria by TNF and other factors. Journal of Immunology 1998, 161:1447-1453.
4. Nicoletti P. Vaccination against Brucella. Advances in Biotechnological Processes 1990, 13:147-168.
5. Schurig G.G., Sriranganathan N., Corbel M.J. Brucellosis vaccines: past, present and future. Veterinary Microbiology 2002, 90:479-496.
6. Moriyon I., Grillo M.J., Monreal D., Gonzalez D., Mari{dotless}ón C. Rough vaccines in animal brucellosis: structural and genetic basis and present status. Veterinary Research 2004, 35:1-38.
7. Dubray G. Le peptidoglycane des Brucella: mise en évidence d'une structure a'triple feuillet. Comptes Rendus de Academic Science Paris 1973, 277:2281-2283.
8. Sowa B.A., Kelly K.A., Ficht T.A., Frey M., Adams L.G. SDS-soluble and peptidoglycan-bound proteins in the outer membrane-peptidoglycan complex of Brucella abortus. Veterinary Microbiology 1991, 27:351-369.
9. Cloeckaert A., Salih-Alj, Debbarh H., Zygmunt M.S., Dubray G. Production and characterisation of monoclonal antibodies to Brucella melitensis cytosoluble proteins that are able to differentiate antibody responses of infected sheep from Rev.1 vaccinated sheep. Journal of Medical Microbiology 1996, 45:206-213.
10. Cloeckaert A., Verger J.M., Grayon M., Zygmunt M.S., Grépinet O. Nucleotide sequence and expression of the gene encoding the major 25-kilodalton outer membrane protein of Brucella ovis: evidence for antigenic shift, compared with other Brucella species, due to a deletion in the gene. Infection and Immunity 1996, 64:2047-2055.
11. Cloeckaert A., Zygmunt M.S., Bezard G., Dubray G. Purification and antigenic analysis of the major 25-kilodalton outer membrane protein of Brucella abortus. Research in Microbiology 1996, 147:225-235.
12. de Wergifosse P., Lintermans P., Limet J.N., Cloeckaert A. Cloning and nucleotide sequence of the gene coding for the major 25-kilodalton outer membrane protein of Brucella abortus. Journal of Bacteriology 1995, 177:1911-1914.
13. Ficht T.A., Bearden S.W., Sowa B.A., Adams L.G. DNA sequence and expression of the 36-kilodalton outer membrane protein gene of Brucella abortus. Infection and Immunity 1989, 57:3281-3291.
14. Vizcaino N., Cloeckaert A., Zygmunt M.S., Dubray G. Cloning, nucleotide sequence, and expression of the Brucella melitensis omp31 gene coding for an immunogenic major outer membrane protein. Infection and Immunity 1996, 64:3744-3751.
15. Tibor A., Weynants V., Denoel P., Lichtfouse B., De Bolle X., Saman E., et al. Molecular cloning, nucleotide sequence, and occurrence of a 16.5-kilodalton outer membrane protein of Brucella abortus with similarity to PAL lipoproteins. Infection and Immunity 1994, 62:3633-3639.
16. Cloeckaert A., Vizcaíno N., Paquet J.Y., Bowden R.A., Elzer P.H. Major outer membrane proteins of Brucella spp.: past, present and future. Veterinary Microbiology 2002, 90:229-247.
17. Critchley R.J., Jezzard S., Radford K.J., Goussard S., Lemoine N.R., Grillot- Courvalin C., et al. Potential therapeutic applications of recombinant, invasive E. coli. Gene Therapy 2004, 11:1224-1233.
18. Isberg R.R., Leong J.M. Multiple beta 1 chain integrins are receptors for invasin, a protein that promotes bacterial penetration into mammalian cells. Cell 1990, 60:861-871.
19. Grillot-Courvalin C., Goussard S., Huetz F., Ojcius D.M., Courvalin P. Functional gene transfer from intracellular bacteria to mammalian cells. Nature Biotechnology 1998, 16:862-866.
20. Harms J.S., Durwad M.A., Magnani D.M., Splitter G.A. Evaluation of recombinant invasive, non-pathogenic Eschericia coli as a vaccine vector against the intracellular pathogen, Brucella. Journal of Immune Based Therapies and Vaccines 2009, 7:1.
21. Higgins D.E., Shastri N., Portnoy D.A. Delivery of protein to the cytosol of macrophages using Escherichia coli K-12. Molecular Microbiology 1999, 31:1631-1641.
22. Hu P.Q., Tuma-Warrino R.J., Bryan M.A., Mitchell K.G., Higgins D.E., Watkins S.C., et al. Escherichia coli expressing recombinant antigen and listeriolysin O stimulate class I-restricted CD8+T cells following uptake by human APC. Journal of Immunology 2004, 172:1595-1601.
23. Radford K.J., et al. A recombinant E. coli vaccine to promote MHC class I-dependent antigen presentation: application to cancer immunotherapy. Gene Therapy 2002, 9:1455-1463.
24. Rana R., Gupta V.K., Vihan V.S. Isolation and characterization of Brucella melitensis 16M from goats. Indian Veterinary and Medical Journal 2002, 26:257-259.
25. Dricot A., Rual J.F., Lamesch P., Bertin N., Dupuy D., Hao T., et al. Generation of the Brucella melitensis ORFeome version 1.1. Genome Research 2004, 14:2201-2206.
26. Cherwonogrodzky J.W., Nielsen K.H. Brucella abortus 1119-3 0-chain polysaccharide to differentiate sera from B. abortus S-19-vaccinated and field-strain-infected cattle by agar gel immunodiffusion. Journal of Clinical Microbiology 1988, 26:1120-1123.
27. Estein S.M., Cassataro J., Vizcaíno N., Zygmunt M.S., Cloeckaert A., Bowden R.A. The recombinant Omp31 from Brucella melitensis alone or associated with rough lipopolysaccharide induces protection against Brucella ovis infection in BALB/c mice. Microbes and Infection 2003, 5:85-93.
28. Debbarh H.S., Cloeckaert A., Zygmunt M.S., Dubray G. Identification of sero-reactive Brucella melitensis cytosoluble proteins which discriminate between antibodies elicited by infection and Rev.1 vaccination in sheep. Veterinary Microbiology 1995, 44:37-48.
29. Lindler L.E., Hadfield T.L., Tall B.D., Snellings N.J., Rubin F.A., Van Deverg L.L., et al. Cloning of a Brucella melitensis group 3 antigens gene encoding Omp-28, a protein recognized by the humoral immune response during human brucellosis. Infection and Immunity 1996, 64:2490-2499.
30. Rossetti O.L., Arese A.I., Boschiroli M.L., Cravero S.L. Cloning of Brucella abortus gene and characterization of expressed 26-kilodalton periplasmic protein: potential use for diagnosis. Journal of Clinical Microbiology 1996, 34:165-169.
31. Salih-Alj Debbarh H., Cloeckaert A., Bézard G., Dubray G., Zygmunt M.S. Enzyme-linked immunosorbent assay with partially purified cytosoluble 28-kilodalton protein for serological differentiation between Brucella melitensis-infected and B. melitensis Rev.1-vaccinated sheep. Clinical and Diagnostic Laboratory Immunology 1996, 3:305-308.
32. Salih-Alj Debbarh H., Zygmunt M.S., Dubray G., Cloeckaert A. Competitive enzyme-linked immunosorbent assay using monoclonal antibodies to the Brucella melitensis BP26 protein to evaluate antibody responses in infected and B. melitensis Rev.1 vaccinated sheep. Veterinary Microbiology 1996, 53:325-337.
33. Pasquevich K.A., García Samartino C., Coria L.M., Estein S.M., Zwerdling A., Ibañez A.E., et al. The protein moiety of Brucella abortus outer membrane protein 16 is a new bacterial pathogen-associated molecular pattern that activates dendritic cells in vivo, induces a Th1 immune response, and is a promising self-adjuvanting vaccine against systemic and oral acquired brucellosis. Journal of Immunology 2010, 184:5200-5212.
34. Golding B., Scott D.E., Scharf O., Huang L.Y., Zaitseva M., Lapham C., et al. Immunity and protection against Brucella abortus. Microbes and Infection 2001, 3:43-48.
35. Oliveira S.C., Splitter G.A. Immunization of mice with recombinant L7/L12 ribosomal protein confers protection against Brucella abortus infection. Vaccine 1996, 14:959-962.
36. Rafiei A., Ardestani S.K., Kariminia A., Keyhani A., Mohraz M., Amirkhani A. Dominant Th1 cytokine production in early onset of human brucellosis followed by switching towards Th2 along prolongation of disease. Journal of Infection 2006, 53:315-324.
37. Caron E., Peyrard T., Köhler S., Cabane S., Liautard J.P., Dornand J.E., et al. Brucella spp. release a specific, protease-sensitive, inhibitor of TNF-α expression, active on human but not on murine macrophage-like cells. Journal of Immunology 1996, 156:2885-2893.
38. Caron E.J., Liautard P., Kohler S. Differentiated U-937 exhibit increased bactericidal activity upon LPS activation and discriminate between virulent and avirulent Listeria and Brucella species. Journal of Leukocyte Biology 1994, 56:174-181.
39. Jiang X., Baldwin C.L. Effects of cytokines on intracellular growth of Brucella abortus. Infection and Immunity 1993, 61:124-134.
40. Jones S.M., Winter A.J. Survival of virulent and attenuated strains of Brucella abortus in normal and gamma interferon-activated murine peritoneal macrophages. Infection and Immunity 1992, 60:3011-3014.
41. Stevens M.G., Pugh G.W., Tabatabai L.B. Effects of gamma interferon and indomethacin in preventing Brucella abortus infections in mice. Infection and Immunity 1992, 60:4407-4409.
42. Yingst S., Hoover D.L. T cell immunity to brucellosis. Critical Reviews in Microbiology 2003, 29:313-331.
43. Araya L.N., Elzer P.H., Rowe G.E., Enright F.M., Winter A.J. Temporal development of protective cell-mediated and humoral immunity in BALB/c mice infected with Brucella abortus. Journal of Immunology 1989, 143:3330-3337.
44. Billard E., Dornand J., Gross A. Interaction of Brucella suis and Brucella abortus rough strains with human dendritic cells. Infection and Immunity 2007, 75:5916-5923.
45. Nitcheu-Tefit J., Dai M.S., Critchley-Thorne R.J., Ramirez-Jimenez F., Xu M., Conchon S., et al. expressed in a bacterial vaccine suppresses CD4+CD25high regulatory T cell function in vivo. Journal of Immunology 2007, 179:1532-1541.
46. Billard E., Cazevieille C., Dornand J., Gross A. High susceptibility of human dendritic cells to invasion by the intracellular pathogens Brucella suis, B. abortus, and B. melitensis. Infection and Immunity 2005, 73:8418-8424.